• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

牛肺和人胎盘中的人干扰素高亲和力受体。

High-affinity receptors for human interferon in bovine lung and human placenta.

作者信息

Branca A A

出版信息

J Interferon Res. 1986 Jun;6(3):305-11. doi: 10.1089/jir.1986.6.305.

DOI:10.1089/jir.1986.6.305
PMID:2943829
Abstract

Membrane fractions were prepared from fresh frozen bovine lung tissue and human placenta and used for receptor binding studies with recombinant DNA produced human-alpha-interferon (IFN-alpha). A single class of high-affinity binding sites was determined for bovine lung (Ka = 1.5 X 10(10) M) and human placenta (Ka = 3.7 X 10(9) M) membranes, respectively. These values for the affinity of IFN binding are comparable within the range of observed error to that observed for the binding of human IFN-alpha 2 to cultured Daudi cells (Ka = 2.5 X 10(10) M). The type I IFN receptor content of bovine lung and human placenta membranes was 1.3 and 2.5 fmoles/mg wet weight, respectively. In addition, alterations in specific and nonspecific binding were observed with the bovine lung membrane incubations in the presence of calcium. Increases in specific binding of three- to fourfold were observed in the presence of 1 mM calcium chloride.

摘要

从新鲜冷冻的牛肺组织和人胎盘中制备膜组分,并用于与重组DNA产生的人α-干扰素(IFN-α)进行受体结合研究。分别测定了牛肺(Ka = 1.5×10¹⁰ M)和人胎盘(Ka = 3.7×10⁹ M)膜的一类高亲和力结合位点。这些IFN结合亲和力的值在观察误差范围内与观察到的人IFN-α 2与培养的Daudi细胞结合的值(Ka = 2.5×10¹⁰ M)相当。牛肺和人胎盘膜的I型IFN受体含量分别为1.3和2.5 fmol/mg湿重。此外,在存在钙的情况下进行牛肺膜孵育时,观察到特异性和非特异性结合的变化。在存在1 mM氯化钙的情况下,观察到特异性结合增加了三到四倍。

相似文献

1
High-affinity receptors for human interferon in bovine lung and human placenta.牛肺和人胎盘中的人干扰素高亲和力受体。
J Interferon Res. 1986 Jun;6(3):305-11. doi: 10.1089/jir.1986.6.305.
2
Bovine spleen, a convenient source for purifying a type I interferon receptor.牛脾脏,一种用于纯化I型干扰素受体的便利来源。
J Interferon Res. 1987 Feb;7(1):77-85. doi: 10.1089/jir.1987.7.77.
3
Receptors for human interferon alpha on bovine cells: specificity and tissue distribution.牛细胞上的人α干扰素受体:特异性与组织分布
Immunopharmacol Immunotoxicol. 1990;12(3):513-25. doi: 10.3109/08923979009006475.
4
Characterization of human interferon-gamma receptor purified from placenta.从胎盘中纯化的人γ-干扰素受体的特性分析。
J Interferon Res. 1989 Dec;9(6):719-30. doi: 10.1089/jir.1989.9.719.
5
Complex binding of the embryonic interferon, ovine trophoblast protein-1, to endometrial receptors.
J Interferon Res. 1989 Apr;9(2):215-25. doi: 10.1089/jir.1989.9.215.
6
Binding of recombinant-produced interferon beta ser to human lymphoblastoid cells. Evidence for two binding domains.重组生产的干扰素βser与人淋巴母细胞样细胞的结合。两个结合域的证据。
J Biol Chem. 1987 Nov 25;262(33):16142-9.
7
Complex kinetics of binding of human alpha-2 interferon to human, but not bovine cells.人α-2干扰素与人细胞而非牛细胞结合的复杂动力学。
J Interferon Res. 1984 Fall;4(4):553-9. doi: 10.1089/jir.1984.4.553.
8
Binding of human alpha-interferon in the brain tissue membranes of rat.
Res Commun Chem Pathol Pharmacol. 1992 Jan;75(1):117-20.
9
Detection and analysis of interferon-alpha receptors on plasma membranes and in detergent extracts.质膜和去污剂提取物中α-干扰素受体的检测与分析
J Interferon Res. 1990 Jun;10(3):299-307. doi: 10.1089/jir.1990.10.299.
10
Different binding of human interferon alpha 1 and alpha 2 to common receptors on human and bovine cells. Studies with recombination interferons produced in Escherichia coli.人干扰素α1和α2与人和牛细胞上共同受体的不同结合。对大肠杆菌中产生的重组干扰素的研究。
J Biol Chem. 1983 Aug 10;258(15):9046-9.

引用本文的文献

1
Low-dose oral interferon modulates expression of inflammatory and autoimmune genes in cattle.低剂量口服干扰素可调节牛体内炎症和自身免疫基因的表达。
Vet Immunol Immunopathol. 2016 Apr;172:64-71. doi: 10.1016/j.vetimm.2016.03.006. Epub 2016 Mar 4.
2
Interferon receptors.干扰素受体
In Vitro Cell Dev Biol. 1988 Mar;24(3):155-65. doi: 10.1007/BF02623541.